Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...
According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” ...
Advancements in Gene Editing Technology and Expansion of Oncology Research to Expand Demand for Humanized Mice ModelsRockville, MD, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The humanized mice model market is ...
Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback